189 related articles for article (PubMed ID: 22838493)
1. Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia.
Hauswald H; Zwicker F; Rochet N; Uhl M; Hensley F; Debus J; Herfarth K; Bischof M
Radiat Oncol; 2012 Jul; 7():118. PubMed ID: 22838493
[TBL] [Abstract][Full Text] [Related]
2. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
[TBL] [Abstract][Full Text] [Related]
3. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
[TBL] [Abstract][Full Text] [Related]
4. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
[TBL] [Abstract][Full Text] [Related]
5. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
[TBL] [Abstract][Full Text] [Related]
6. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
Elsayad K; Kriz J; Moustakis C; Scobioala S; Reinartz G; Haverkamp U; Willich N; Weishaupt C; Stadler R; Sunderkötter C; Eich HT
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1077-86. PubMed ID: 26581145
[TBL] [Abstract][Full Text] [Related]
7. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
Quiros PA; Kacinski BM; Wilson LD
Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
[TBL] [Abstract][Full Text] [Related]
8. Total Skin Electron Beam Therapy with Rotary Dual Technique as Palliative Treatment for Mycosis Fungoides.
Piotrowski T; Fundowicz M; Pawlaczyk M
In Vivo; 2018; 32(3):517-522. PubMed ID: 29695554
[TBL] [Abstract][Full Text] [Related]
9. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
10. Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique.
Heumann TR; Esiashvili N; Parker S; Switchenko JM; Dhabbaan A; Goodman M; Lechowicz MJ; Flowers CR; Khan MK
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):183-91. PubMed ID: 25670538
[TBL] [Abstract][Full Text] [Related]
11. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
[TBL] [Abstract][Full Text] [Related]
12. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma.
Wilson LD; Quiros PA; Kolenik SA; Heald PW; Braverman IM; Edelson RL; Kacinski BM
J Am Acad Dermatol; 1996 Jul; 35(1):69-73. PubMed ID: 8682967
[TBL] [Abstract][Full Text] [Related]
13. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma.
Thomas TO; Agrawal P; Guitart J; Rosen ST; Rademaker AW; Querfeld C; Hayes JP; Kuzel TM; Mittal BB
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):747-53. PubMed ID: 22818412
[TBL] [Abstract][Full Text] [Related]
15. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal Skin Electron Therapy.
Laughlin BS; Zaniletti I; Foster MG; Lucido J; Mangold AR; Rosenthal AC; VAN DER Walt C; Breen W; Lester S; Hoppe B; Petersen J; Armstrong MD; Bogan A; Rule WG
Anticancer Res; 2024 Apr; 44(4):1491-1497. PubMed ID: 38537978
[TBL] [Abstract][Full Text] [Related]
16. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
Elsayad K; Susek KH; Eich HT
Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
[TBL] [Abstract][Full Text] [Related]
17. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
18. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
Rolf D; Elsayad K; Eich HT
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous lymphoma: local control and survival in patients treated with radiotherapy.
De Sanctis V; Osti MF; Berardi F; Ardito F; Valeriani M; Martelli M; Enrici RM
Anticancer Res; 2007; 27(1B):601-5. PubMed ID: 17348448
[TBL] [Abstract][Full Text] [Related]
20. [Experience of local radiation therapy and total irradiation of the skin by electron beam in patients with primary B and T-cell lymphomas of the skin].
Il'in NV; Korytova LI; Leenman EE; Vinogradova IuN; Nikolaeva EN; Gracheva AV; Cherviakov AM
Vopr Onkol; 2013; 59(1):109-13. PubMed ID: 23814836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]